>Marché européen des solvants pharmaceutiques, par produit (alcools, hydrocarbures aromatiques, cétones, éthers, amines, esters, solvants chlorés et autres), application (pharmaceutique, laboratoires de recherche, chimie et autres), pays (Allemagne, France, Royaume-Uni, Italie, Espagne, Pays-Bas, Suisse, Russie, Turquie, Belgique, reste de l'Europe), tendances de l'industrie et prévisions jusqu'en 2028.
Analyse et perspectives du marché : marché européen des solvants pharmaceutiques
Le marché européen des solvants pharmaceutiques devrait connaître une croissance significative au cours de la période de prévision de 2021 à 2028. Data Bridge Market Research analyse que le marché croît avec un TCAC de 4,5 % au cours de la période de prévision de 2021 à 2028 et devrait atteindre 1 689 861,89 milliers de dollars d'ici 2028. L'augmentation de la demande de médicaments devrait stimuler la croissance du marché.
Les solvants pharmaceutiques désignent des composés chimiques principalement utilisés dans la fabrication de médicaments dans l'industrie pharmaceutique. Ces solvants sont utilisés pour dissoudre d'autres produits et composants et trouvent leur utilité en tant que bloc de fabrication en fournissant les molécules nécessaires à la production de médicaments et de produits pharmaceutiques. Ces solvants sont également utilisés dans le processus d'extraction et de purification. La plupart des solvants pharmaceutiques ne peuvent pas être complètement éliminés des médicaments finaux. Il est cependant souhaitable qu'un solvant pharmaceutique ne modifie pas les propriétés de l'un ou l'autre des produits chimiques impliqués dans la réaction.
Ces solvants alcooliques sont utilisés dans de nombreux médicaments pharmaceutiques majeurs tels que le glycol, l'isopropanol et l'éthanol et la croissance du secteur pharmaceutique et de la santé est le principal facteur de croissance du marché. En outre, les coûts de production élevés et le processus de fabrication complexe constituent un frein à la croissance du marché. D'autre part, les activités croissantes de recherche et développement et le développement de nouvelles méthodes et technologies de fabrication de médicaments constituent une opportunité pour le marché. Cependant, l'augmentation des préoccupations concernant la toxicité des solvants pourrait créer des défis supplémentaires pour la croissance du marché.
Le rapport sur le marché européen des solvants pharmaceutiques fournit des détails sur la part de marché, les nouveaux développements et l'analyse du pipeline de produits, l'impact des acteurs du marché national et local, analyse les opportunités en termes de poches de revenus émergentes, de changements dans la réglementation du marché, d'approbations de produits, de décisions stratégiques, de lancements de produits, d'expansions géographiques et d'innovations technologiques sur le marché. Pour comprendre l'analyse et le scénario du marché européen des solvants pharmaceutiques, contactez Data Bridge Market Research pour un briefing d'analyste ; notre équipe vous aidera à créer une solution d'impact sur les revenus pour atteindre votre objectif souhaité.
Portée et taille du marché européen des solvants pharmaceutiques
The Europe pharmaceutical solvent market is segmented based on product and application. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of product, the Europe pharmaceutical solvent market is segmented alcohol, aromatic hydrocarbons, ketones, ethers, amine, esters, chlorinated solvents and others. In 2021, the alcohol segment is expected to dominate the Europe pharmaceutical solvent market due to growing usage of alcoholic solvents in OTC drugs and syrups, antifreeze, soaps, dyes, and many cleaning agents in the Europe region.
- On the basis of application, the Europe pharmaceutical solvent market is segmented into pharmaceutical, research laboratories, chemical and others. In 2021, the pharmaceutical segment is expected to dominate the market due to rising usage in formulations to reduce drugs' unpleasant/ bitter taste in the region.
Europe Pharmaceutical solvent market Country Level Analysis
The Europe pharmaceutical solvent market is analyzed, and market size information is provided by the country, product, and application referenced above.
The countries covered in the Europe pharmaceutical solvent market report are Germany, France, Spain, Italy, Netherlands, Turkey, the U.K., Belgium, Portugal, Luxembourg, Russia, Switzerland, the Rest of Europe. Germany dominates the Europe pharmaceutical solvent market due to the high demand for solvent in the country in pharma sector to research on new medicine.
The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of European brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.
Rise in Urbanization and Disposable Income is Boosting the Growth of Europe Pharmaceutical Solvent Market
The Europe pharmaceutical solvent market also provides you with a detailed market analysis for every country's growth in a particular market. Additionally, it provides detailed information regarding the market players’ strategy and their geographical presence. The data is available for the historical period 2010 to 2019.
Competitive Landscape and Europe Pharmaceutical Solvent Market Share Analysis
Le paysage concurrentiel du marché européen des solvants pharmaceutiques fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, les sites et installations de production, les forces et les faiblesses de l'entreprise, le lancement de produits, les pipelines d'essais de produits, les approbations de produits, les brevets, la largeur et l'étendue du produit, la domination des applications et la courbe de survie technologique. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises par rapport au marché européen des solvants pharmaceutiques.
Certaines des principales entreprises opérant sur le marché européen des solvants pharmaceutiques sont BASF SE, Royal Dutch Shell Plc, Merck KGaA, Brenntag SE, DuPont, Clariant AG, Dow, LyondellBasell Industries Holdings BV et Exxon Mobil Corporation, entre autres. Les analystes de DBMR comprennent les atouts concurrentiels et fournissent une analyse concurrentielle pour chaque concurrent séparément.
De nombreux contrats et accords sont également initiés par les entreprises du monde entier, ce qui accélère encore la croissance du marché européen des solvants pharmaceutiques.
Par exemple,
- En juillet 2021, DuPont a finalisé l'acquisition de Laird Performance Materials, un leader mondial des solutions de blindage électromagnétique et de gestion thermique hautes performances.
Cela aidera l’entreprise à élargir sa clientèle et son échelle mondiale pour accélérer sa mise sur le marché.
- En octobre 2021, Brenntag SE a conclu un accord avec NXTLEVVEL Biochem, spécialiste des solvants biosourcés. Cet accord a permis à l'entreprise d'étendre sa distribution dans les secteurs domestique et commercial.
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE PHARMACEUTICAL SOLVENT MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRODUCT LIFE LINE CURVE
2.7 MULTIVARIATE MODELLING
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET APPLICATION COVERAGE GRID
2.12 DBMR MARKET CHALLENGE MATRIX
2.13 SECONDARY SOURCES
2.14 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 RAW MATERIAL OUTLOOK
4.2 ADOPTION SCENARIO AMONG BUYERS
4.3 VALUE CHAIN ANALYSIS
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 GROWTH IN PHARMACEUTICAL, AND HEALTHCARE SECTOR ACROSS THE GLOBE
5.1.2 RISE IN PRODUCTION OF INNOVATIVE GENERIC DRUGS, PARTICULARLY IN EMERGING ECONOMIES
5.1.3 INCREASE IN DEMAND FOR ALCOHOL SOLVENTS FOR MANUFACTURING OF VARIOUS DRUGS
5.2 RESTRAINTS
5.2.1 HIGH PRODUCTION COSTS, AND COMPLEX MANUFACTURING PROCESS
5.2.2 STRINGENT REGULATIONS REGARDING THE USE OF CERTAIN CONVENTIONAL SOLVENTS
5.3 OPPORTUNITIES
5.3.1 GROWTH IN RESEARCH AND DEVELOPMENT ACTIVITIES
5.3.2 DEVELOPMENT OF NEW DRUG MANUFACTURING METHODS AND TECHNOLOGIES
5.3.3 RISE IN ADOPTION OF GREEN MATERIALS AND CHEMICALS FOR DRUG MANUFACTURING
5.4 CHALLENGES
5.4.1 RISE IN CONCERNS REGARDING THE TOXICITY OF SOLVENTS
5.4.2 OCCURRENCES OF FATALITIES IN THE PHARMACEUTICAL SOLVENT MANUFACTURING COMPANIES
6 ANALYSIS ON IMPACT OF COVID-19 ON THE MARKET
6.1 AFTERMATH OF COVID-19 AND THE GOVERNMENT INITIATIVE TO BOOST THE MARKET
6.2 STRATEGIC DECISIONS OF MANUFACTURERS AFTER COVID-19 TO GET COMPETITIVE MARKET SHARE
6.3 IMPACT ON PRICE
6.4 IMPACT ON DEMAND
6.5 IMPACT ON SUPPLY CHAIN
6.6 CONCLUSION
7 EUROPE PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT
7.1 OVERVIEW
7.2 ALCOHOL
7.2.1 METHANOL
7.2.2 ETHANOL
7.2.3 1-BUTANOL
7.2.4 2-BUTANOL
7.2.5 2-METHOXYETHANOL
7.2.6 3-METHYL-1-PROPANOL
7.2.7 2-METHYL-1-PROPANOL
7.2.8 1-PENTANOL
7.2.9 1-PROPANOL
7.2.10 2-PROPANOL (ISOPROPYL ALCOHOL)
7.2.11 OTHERS
7.3 AROMATIC HYDROCARBONS
7.3.1 TOLUENE
7.3.2 XYLENE
7.3.3 ETHYLBENZENE
7.3.4 OTHERS
7.4 KETONES
7.4.1 ACETONE
7.4.2 CYCLOHEXANONE
7.4.3 METHYL ETHER KETONE
7.4.4 METHYL ETHYL KETONE
7.4.5 METHYL ISOBUTYL KETONE
7.4.6 OTHERS
7.5 ETHERS
7.5.1 DIETHYL ETHER
7.5.2 METHOXYETHANE
7.5.3 TETRAHYDROFURAN
7.5.4 METHYL TERT-BUTYL ETHER
7.5.5 DI-N-PROPYL ETHER
7.5.6 OTHERS
7.6 AMINE
7.6.1 MONOETHANOLAMINE (MEA)
7.6.2 DIETHANOLAMINE (DEA)
7.6.3 METHYLDIETHANOLAMINE (MDEA)
7.6.4 OTHERS
7.7 ESTERS
7.7.1 ACETYL ACETATE
7.7.2 ETHYL ACETATE
7.7.3 BUTYL ACETATE
7.7.4 OTHERS
7.8 CHLORINATED SOLVENTS
7.8.1 TRICHLOROETHYLENE (TCE)
7.8.2 PERCHLOROETHYLENE (PCE)
7.8.3 1,1,1-TRICHLOROETHANE (TCA)
7.8.4 OTHERS
7.9 OTHERS
8 EUROPE PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 PHARMACEUTICAL
8.3 RESEARCH LABORATORIES
8.4 CHEMICAL
8.5 OTHERS
9 EUROPE PHARMACEUTICAL SOLVENT MARKET
9.1 EUROPE
9.1.1 SWITZERLAND
9.1.2 ITALY
9.1.3 GERMANY
9.1.4 FRANCE
9.1.5 U.K.
9.1.6 SPAIN
9.1.7 BELGIUM
9.1.8 NETHERLANDS
9.1.9 RUSSIA
9.1.10 TURKEY
9.1.11 LUXEMBURG
9.1.12 REST OF EUROPE
10 EUROPE PHARMACEUTICAL SOLVENT MARKET: COMPANY LANDSCAPE
10.1 COMPANY SHARE ANALYSIS: EUROPE
10.2 MERGERS & ACQUISITIONS
10.3 EXPANSION
10.4 NEW PRODUCT DEVELOPMENT
10.5 PARTNERSHIP
10.6 AGREEMENTS
10.7 AWARD AND CERTIFICATION
11 SWOT ANALYSIS
12 COMPANY PROFILE
12.1 ROYAL DUTCH SHELL PLC
12.1.1 COMPANY SNAPSHOT
12.1.2 REVENUS ANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 PRODUCT PORTFOLIO
12.1.5 RECENT DEVELOPMENT
12.2 BASF SE
12.2.1 COMPANY SNAPSHOT
12.2.2 REVENUS ANALYSIS
12.2.3 COMPANY SHARE ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENT
12.3 MERCK KGAA
12.3.1 COMPANY SNAPSHOT
12.3.2 REVENUE ANALYSIS
12.3.3 COMPANY SHARE ANALYSIS
12.3.4 PRODUCT PORTFOLIO
12.3.5 RECENT DEVELOPMENT
12.4 EXXON MOBIL CORPORATION
12.4.1 COMPANY SNAPSHOT
12.4.2 REVENUE ANALYSIS
12.4.3 COMPANY SHARE ANALYSIS
12.4.4 PRODUCT PORTFOLIO
12.4.5 RECENT DEVELOPMENT
12.5 BRENNTAG SE
12.5.1 COMPANY SNAPSHOT
12.5.2 REVENUE ANALYSIS
12.5.3 COMPANY SHARE ANALYSIS
12.5.4 PRODUCT PORTFOLIO
12.5.5 RECENT DEVELOPMENT
12.6 DUPONT
12.6.1 COMPANY SNAPSHOT
12.6.2 REVENUS ANALYSIS
12.6.3 PRODUCT PORTFOLIO
12.6.4 RECENT DEVELOPMENTS
12.7 MITSUI CHEMICALS
12.7.1 COMPANY SNAPSHOT
12.7.2 REVENUE ANALYSIS
12.7.3 PRODUCT PORTFOLIO
12.7.4 RECENT DEVELOPMENT
12.8 DOW
12.8.1 COMPANY SNAPSHOT
12.8.2 REVENUS ANALYSIS
12.8.3 PRODUCT PORTFOLIO
12.8.4 RECENT DEVELOPMENT
12.9 LYONDELLBASELL INDUSTRIES HOLDINGS B.V.
12.9.1 COMPANY SNAPSHOT
12.9.2 REVENUS ANALYSIS
12.9.3 PRODUCT PORTFOLIO
12.9.4 RECENT DEVELOPMENT
12.1 CLARIANT AG
12.10.1 COMPANY SNAPSHOT
12.10.2 REVENUE ANALYSIS
12.10.3 PRODUCT PORTFOLIO
12.10.4 RECENT DEVELOPMENT
12.11 AVANTOR, INC.
12.11.1 COMPANY SNAPSHOT
12.11.2 REVENUE ANALYSIS
12.11.3 PRODUCT PORTFOLIO
12.11.4 RECENT DEVELOPMENT
12.12 EASTMAN CHEMICAL COMPANY
12.12.1 COMPANY SNAPSHOT
12.12.2 REVENUS ANALYSIS
12.12.3 PRODUCT PORTFOLIO
12.12.4 RECENT DEVELOPMENT
12.13 OLIN CORPORATION
12.13.1 COMPANY SNAPSHOT
12.13.2 REVENUE ANALYSIS
12.13.3 PRODUCT PORTFOLIO
12.13.4 RECENT DEVELOPMENT
12.14 SK GEO CENTRIC CO., LTD. (A SUBSIDIARY OF SK EUROPE CHEMICAL)
12.14.1 COMPANY SNAPSHOT
12.14.2 PRODUCT PORTFOLIO
13 QUESTIONNAIRE
14 RELATED REPORTS
Liste des tableaux
TABLE 1 INNOVATORS OF GENERIC DRUGS
TABLE 2 DRUGS DEVELOPMENT IN THE YEAR 2021
TABLE 3 CLASSES OF SOLVENTS AND THEIR HARMFUL EFFECTS
TABLE 4 EUROPE PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 5 EUROPE PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 6 EUROPE ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 7 EUROPE ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)
TABLE 8 EUROPE ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 9 EUROPE ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 10 EUROPE AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 11 EUROPE AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)
TABLE 12 EUROPE AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 13 EUROPE AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 14 EUROPE KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 15 EUROPE KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)
TABLE 16 EUROPE KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 17 EUROPE KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 18 EUROPE ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 19 EUROPE ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS )
TABLE 20 EUROPE ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 21 EUROPE ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 22 EUROPE AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 23 EUROPE AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)
TABLE 24 EUROPE AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 25 EUROPE AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 26 EUROPE ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 27 EUROPE ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)
TABLE 28 EUROPE ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 29 EUROPE ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 30 EUROPE CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 31 EUROPE CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)
TABLE 32 EUROPE CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 33 EUROPE CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 34 EUROPE OTHERS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 35 EUROPE CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)
TABLE 36 EUROPE PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (USD THOUSAND)
TABLE 37 EUROPE PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (THOUSAND TONS)
TABLE 38 EUROPE PHARMACEUTICAL IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 39 EUROPE PHARMACEUTICAL IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)
TABLE 40 EUROPE RESEARCH LABORATORIES IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 41 EUROPE RESEARCH LABORATORIES IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)
TABLE 42 EUROPE CHEMICAL IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 43 EUROPE CHEMICAL IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)
TABLE 44 EUROPE OTHERS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 45 EUROPE OTHERS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)
TABLE 46 EUROPE PHARMACEUTICAL SOLVENT MARKET, BY COUNTRY, 2019-2028 (USD THOUSAND)
TABLE 47 EUROPE PHARMACEUTICAL SOLVENT MARKET, BY COUNTRY, 2019-2028 (THOUSAND TONS)
TABLE 48 EUROPE PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 49 EUROPE PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 50 EUROPE ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 51 EUROPE ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 52 EUROPE AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 53 EUROPE AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 54 EUROPE KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 55 EUROPE KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 56 EUROPE ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 57 EUROPE ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 58 EUROPE AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 59 EUROPE AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 60 EUROPE ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 61 EUROPE ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 62 EUROPE CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 63 EUROPE CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 64 EUROPE PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (USD THOUSAND)
TABLE 65 EUROPE PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (THOUSAND TONS)
TABLE 66 SWITZERLAND PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 67 SWITZERLAND PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 68 SWITZERLAND ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 69 SWITZERLAND ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 70 SWITZERLAND AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 71 SWITZERLAND AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 72 SWITZERLAND KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 73 SWITZERLAND KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 74 SWITZERLAND ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 75 SWITZERLAND ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 76 SWITZERLAND AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 77 SWITZERLAND AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 78 SWITZERLAND ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 79 SWITZERLAND ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 80 SWITZERLAND CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 81 SWITZERLAND CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 82 SWITZERLAND PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (USD THOUSAND)
TABLE 83 SWITZERLAND PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (THOUSAND TONS)
TABLE 84 ITALY PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 85 ITALY PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 86 ITALY ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 87 ITALY ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 88 ITALY AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 89 ITALY AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 90 ITALY KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 91 ITALY KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 92 ITALY ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 93 ITALY ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 94 ITALY AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 95 ITALY AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 96 ITALY ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 97 ITALY ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 98 ITALY CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 99 ITALY CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 100 ITALY PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (USD THOUSAND)
TABLE 101 ITALY PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (THOUSAND TONS)
TABLE 102 GERMANY PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 103 GERMANY PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 104 GERMANY ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 105 GERMANY ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 106 GERMANY AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 107 GERMANY AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 108 GERMANY KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 109 GERMANY KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 110 GERMANY ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 111 GERMANY ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 112 GERMANY AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 113 GERMANY AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 114 GERMANY ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 115 GERMANY ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 116 GERMANY CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 117 GERMANY CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 118 GERMANY PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (USD THOUSAND)
TABLE 119 GERMANY PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (THOUSAND TONS)
TABLE 120 FRANCE PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 121 FRANCE PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 122 FRANCE ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 123 FRANCE ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 124 FRANCE AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 125 FRANCE AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 126 FRANCE KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 127 FRANCE KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 128 FRANCE ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 129 FRANCE ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 130 FRANCE AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 131 FRANCE AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 132 FRANCE ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 133 FRANCE ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 134 FRANCE CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 135 FRANCE CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 136 FRANCE PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (USD THOUSAND)
TABLE 137 FRANCE PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (THOUSAND TONS)
TABLE 138 U.K. PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 139 U.K. PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 140 U.K. ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 141 U.K. ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 142 U.K. AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 143 U.K. AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 144 U.K. KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 145 U.K. KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 146 U.K. ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 147 U.K. ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 148 U.K. AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 149 U.K. AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 150 U.K. ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 151 U.K. ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 152 U.K. CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 153 U.K. CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 154 U.K. PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (USD THOUSAND)
TABLE 155 U.K. PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (THOUSAND TONS)
TABLE 156 SPAIN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 157 SPAIN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 158 SPAIN ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 159 SPAIN ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 160 SPAIN AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 161 SPAIN AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 162 SPAIN KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 163 SPAIN KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 164 SPAIN ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 165 SPAIN ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 166 SPAIN AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 167 SPAIN AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 168 SPAIN ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 169 SPAIN ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 170 SPAIN CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 171 SPAIN CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 172 SPAIN PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (USD THOUSAND)
TABLE 173 SPAIN PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (THOUSAND TONS)
TABLE 174 BELGIUM PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 175 BELGIUM PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 176 BELGIUM ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 177 BELGIUM ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 178 BELGIUM AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 179 BELGIUM AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 180 BELGIUM KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 181 BELGIUM KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 182 BELGIUM ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 183 BELGIUM ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 184 BELGIUM AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 185 BELGIUM AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 186 BELGIUM ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 187 BELGIUM ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 188 BELGIUM CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 189 BELGIUM CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 190 BELGIUM PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (USD THOUSAND)
TABLE 191 BELGIUM PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (THOUSAND TONS)
TABLE 192 NETHERLANDS PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 193 NETHERLANDS PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 194 NETHERLANDS ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 195 NETHERLANDS ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 196 NETHERLANDS AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 197 NETHERLANDS AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 198 NETHERLANDS KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 199 NETHERLANDS KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 200 NETHERLANDS ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 201 NETHERLANDS ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 202 NETHERLANDS AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 203 NETHERLANDS AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 204 NETHERLANDS ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 205 NETHERLANDS ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 206 NETHERLANDS CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 207 NETHERLANDS CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 208 NETHERLANDS PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (USD THOUSAND)
TABLE 209 NETHERLANDS PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (THOUSAND TONS)
TABLE 210 RUSSIA PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 211 RUSSIA PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 212 RUSSIA ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 213 RUSSIA ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 214 RUSSIA AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 215 RUSSIA AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 216 RUSSIA KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 217 RUSSIA KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 218 RUSSIA ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 219 RUSSIA ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 220 RUSSIA AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 221 RUSSIA AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 222 RUSSIA ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 223 RUSSIA ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 224 RUSSIA CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 225 RUSSIA CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 226 RUSSIA PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (USD THOUSAND)
TABLE 227 RUSSIA PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (THOUSAND TONS)
TABLE 228 TURKEY PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 229 TURKEY PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 230 TURKEY ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 231 TURKEY ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 232 TURKEY AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 233 TURKEY AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 234 TURKEY KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 235 TURKEY KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 236 TURKEY ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 237 TURKEY ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 238 TURKEY AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 239 TURKEY AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 240 TURKEY ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 241 TURKEY ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 242 TURKEY CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 243 TURKEY CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 244 TURKEY PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (USD THOUSAND)
TABLE 245 TURKEY PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (THOUSAND TONS)
TABLE 246 LUXEMBURG PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 247 LUXEMBURG PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 248 LUXEMBURG ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 249 LUXEMBURG ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 250 LUXEMBURG AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 251 LUXEMBURG AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 252 LUXEMBURG KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 253 LUXEMBURG KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 254 LUXEMBURG ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 255 LUXEMBURG ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 256 LUXEMBURG AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 257 LUXEMBURG AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 258 LUXEMBURG ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 259 LUXEMBURG ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 260 LUXEMBURG CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 261 LUXEMBURG CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 262 LUXEMBURG PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (USD THOUSAND)
TABLE 263 LUXEMBURG PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (THOUSAND TONS)
TABLE 264 REST OF EUROPE PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 265 REST OF EUROPE PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
Liste des figures
FIGURE 1 EUROPE PHARMACEUTICAL SOLVENT MARKET: SEGMENTATION
FIGURE 2 EUROPE PHARMACEUTICAL SOLVENT MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE PHARMACEUTICAL SOLVENT MARKET: DROC ANALYSIS
FIGURE 4 EUROPE PHARMACEUTICAL SOLVENT MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE PHARMACEUTICAL SOLVENT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE PHARMACEUTICAL SOLVENT MARKET: PRODUCT LIFELINE CURVE
FIGURE 7 EUROPE PHARMACEUTICAL SOLVENT MARKET: MULTIVARIATE MODELLING
FIGURE 8 EUROPE PHARMACEUTICAL SOLVENT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 9 EUROPE PHARMACEUTICAL SOLVENT MARKET: DBMR POSITION GRID
FIGURE 10 EUROPE PHARMACEUTICAL SOLVENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 EUROPE PHARMACEUTICAL SOLVENT MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 12 EUROPE PHARMACEUTICAL SOLVENT: THE MARKET CHALLENGE MATRIX
FIGURE 13 EUROPE PHARMACEUTICAL SOLVENT MARKET: SEGMENTATION
FIGURE 14 ASIA-PACIFIC REGION IS EXPECTED TO DOMINATE THE EUROPE PHARMACEUTICAL SOLVENT MARKET, AND TO GROW WITH THE HIGHEST CAGR FROM 2021 TO 2028
FIGURE 15 THE GROWING PHARMACEUTICAL AND HEALTHCARE SECTOR ACROSS THE GLOBE IS DRIVING THE GROWTH OF THE EUROPE PHARMACEUTICAL SOLVENT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 16 ALCOHOL SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE PHARMACEUTICAL SOLVENT MARKET IN 2021 & 2028
FIGURE 17 VALUE CHAIN OF PHARMACEUTICAL SOLVENT
FIGURE 18 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF EUROPE PHARMACEUTICAL SOLVENT MARKET
FIGURE 19 WORLDWIDE GDP PER CAPITA INCOME
FIGURE 20 NEW DRUGS APPROVED BY THE U.S. FOOD AND DRUG ADMINISTRATION (2010-2020)
FIGURE 21 EUROPE PHARMACEUTICAL SOLVENT MARKET: BY PRODUCT, 2020
FIGURE 22 EUROPE PHARMACEUTICAL SOLVENT MARKET: BY APPLICATION, 2020
FIGURE 23 EUROPE PHARMACEUTICAL SOLVENT MARKET: SNAPSHOT (2020)
FIGURE 24 EUROPE PHARMACEUTICAL SOLVENT MARKET: BY COUNTRY (2020)
FIGURE 25 EUROPE PHARMACEUTICAL SOLVENT MARKET: BY COUNTRY (2021 & 2028)
FIGURE 26 EUROPE PHARMACEUTICAL SOLVENT MARKET: BY COUNTRY (2020 & 2028)
FIGURE 27 EUROPE PHARMACEUTICAL SOLVENT MARKET: BY PRODUCT (2021-2028)
FIGURE 28 EUROPE PHARMACEUTICAL SOLVENT MARKET: COMPANY SHARE 2020 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.
